Hutch News

Gentler treatment for many with graft-vs.-host disease

Gentler treatment for many with graft-vs.-host disease

A new study finds halving standard steroid dose treats most acute GVHD just as well; could limit dangerous side effects
Hutch NewsFebruary 19, 2015
Mielcarek lands $2.2 million GVHD grant

Mielcarek lands $2.2 million GVHD grant

NHLBI grant will expand research into protective mechanisms of statins against severe acute graft-vs.-host disease in transplant patients
Hutch NewsMay 16, 2011